alpha-aminopyridine has been researched along with Bronchitis in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horna, O; Toyas, C | 1 |
| Wedzicha, JA | 1 |
| Izquierdo Alonso, JL | 1 |
| Almagro, P; Ancochea, J; Calle, M; López-Campos, JL; Miravitlles, M; Molina, J; Piñera, P; Quintano, JA; Riesco, JA; Simón, A; Soler-Cataluña, JJ; Soriano, JB; Trigueros, JA | 1 |
| Bateman, ED; Briggs, AH; Kotchie, RW; Mörk, AC; Samyshkin, Y | 1 |
1 review(s) available for alpha-aminopyridine and Bronchitis
| Article | Year |
|---|---|
[Clinical profile of roflumilast].
Topics: Adrenal Cortex Hormones; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Aminopyridines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Cyclopropanes; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; Forced Expiratory Volume; Humans; Mice; Middle Aged; Multicenter Studies as Topic; Muscarinic Antagonists; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Rats; Salmeterol Xinafoate; Scopolamine Derivatives; Tiotropium Bromide; Treatment Outcome; Weight Loss | 2010 |
4 other study(ies) available for alpha-aminopyridine and Bronchitis
| Article | Year |
|---|---|
[Intractable diarrhoea and severe weight loss by roflumilast].
Topics: Aged; Aminopyridines; Animals; Anorexia; Benzamides; Bronchitis; Comorbidity; Cyclopropanes; Diarrhea; Drug Evaluation, Preclinical; Female; Gastrointestinal Tract; Hallucinations; Hospitalization; Humans; Patient Readmission; Phosphodiesterase Inhibitors; Polypharmacy; Product Surveillance, Postmarketing; Pulmonary Disease, Chronic Obstructive; Sleep Apnea Syndromes; Vomiting; Weight Loss | 2013 |
The role of the phosphodiesterase-4 inhibitor, roflumilast, in chronic obstructive pulmonary disease.
Topics: Aminopyridines; Anti-Inflammatory Agents; Benzamides; Bronchitis; Cyclopropanes; Forced Expiratory Volume; Humans; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive | 2010 |
Spanish COPD Guidelines (GesEPOC): pharmacological treatment of stable COPD. Spanish Society of Pulmonology and Thoracic Surgery.
Topics: Adrenal Cortex Hormones; alpha 1-Antitrypsin; Aminopyridines; Anti-Bacterial Agents; Asthma; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Comorbidity; Cyclopropanes; Disease Progression; Drug Therapy, Combination; Expectorants; Humans; Phenotype; Pulmonary Disease, Chronic Obstructive; Pulmonary Emphysema; Respiratory System Agents; Severity of Illness Index; Spain; Theophylline | 2012 |
Cost-effectiveness of roflumilast as an add-on treatment to long-acting bronchodilators in the treatment of COPD associated with chronic bronchitis in the United Kingdom.
Topics: Age Factors; Aged; Aminopyridines; Benzamides; Bronchitis; Bronchodilator Agents; Chronic Disease; Clinical Trials as Topic; Cost-Benefit Analysis; Cyclopropanes; Delayed-Action Preparations; Female; Health Services; Humans; Male; Markov Chains; Middle Aged; Phosphodiesterase 4 Inhibitors; Pulmonary Disease, Chronic Obstructive; Quality-Adjusted Life Years; Respiratory Function Tests; United Kingdom | 2014 |